164 related articles for article (PubMed ID: 33539938)
21. Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression.
Barbolina MV; Adley BP; Ariztia EV; Liu Y; Stack MS
J Biol Chem; 2007 Feb; 282(7):4924-4931. PubMed ID: 17158885
[TBL] [Abstract][Full Text] [Related]
22. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
Li H; Zhou Y; Cheng H; Tian J; Yang S
Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
Liu X; Li G
Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
[TBL] [Abstract][Full Text] [Related]
24. Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition.
Yagi H; Yotsumoto F; Miyamoto S
Mol Cancer Ther; 2008 Oct; 7(10):3441-51. PubMed ID: 18852147
[TBL] [Abstract][Full Text] [Related]
25. Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway.
Liu H; Shi H; Fan Q; Sun X
Tumour Biol; 2016 Aug; 37(8):10161-75. PubMed ID: 26831658
[TBL] [Abstract][Full Text] [Related]
26. Proteasomal degradation of eukaryotic elongation factor-2 kinase (EF2K) is regulated by cAMP-PKA signaling and the SCFβTRCP ubiquitin E3 ligase.
Wiseman SL; Shimizu Y; Palfrey C; Nairn AC
J Biol Chem; 2013 Jun; 288(24):17803-11. PubMed ID: 23640883
[TBL] [Abstract][Full Text] [Related]
27. CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro.
Zhu Z; Mu Y; Qi C; Wang J; Xi G; Guo J; Mi R; Zhao F
Int J Mol Med; 2015 Feb; 35(2):340-8. PubMed ID: 25516145
[TBL] [Abstract][Full Text] [Related]
28. Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer.
Yakubov B; Chelladurai B; Schmitt J; Emerson R; Turchi JJ; Matei D
Neoplasia; 2013 Jun; 15(6):609-19. PubMed ID: 23730209
[TBL] [Abstract][Full Text] [Related]
29. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
Zheng B; Geng L; Zeng L; Liu F; Huang Q
Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
[TBL] [Abstract][Full Text] [Related]
30. In vivo selection of highly metastatic human ovarian cancer sublines reveals role for AMIGO2 in intra-peritoneal metastatic regulation.
Liu Y; Yang J; Shi Z; Tan X; Jin N; O'Brien C; Ott C; Grisoli A; Lee E; Volk K; Conroy M; Franz E; Bryant A; Campbell L; Crowley B; Grisoli S; Alexandrou AT; Li C; Harper EI; Asem M; Johnson J; Leonard A; Santanello K; Klein A; Wang Q; Zhang S; Hilliard TS; Stack MS
Cancer Lett; 2021 Apr; 503():163-173. PubMed ID: 33524500
[TBL] [Abstract][Full Text] [Related]
31. miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression.
Ohyagi-Hara C; Sawada K; Kamiura S; Tomita Y; Isobe A; Hashimoto K; Kinose Y; Mabuchi S; Hisamatsu T; Takahashi T; Kumasawa K; Nagata S; Morishige K; Lengyel E; Kurachi H; Kimura T
Am J Pathol; 2013 May; 182(5):1876-89. PubMed ID: 23499550
[TBL] [Abstract][Full Text] [Related]
32. Wilms' tumor 1 (
Han Y; Song C; Zhang T; Zhou Q; Zhang X; Wang J; Xu B; Zhang X; Liu X; Ying X
Cell Cycle; 2020 Oct; 19(20):2662-2675. PubMed ID: 32892698
[TBL] [Abstract][Full Text] [Related]
33. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
Gao P; Wang S; Jing F; Zhan J; Wang Y
Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
[TBL] [Abstract][Full Text] [Related]
34. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of hsa_circ_0026123 suppresses ovarian cancer cell metastasis and proliferation through the miR‑124‑3p/EZH2 signaling pathway.
Yang X; Wang J; Li H; Sun Y; Tong X
Int J Mol Med; 2021 Feb; 47(2):668-676. PubMed ID: 33416105
[TBL] [Abstract][Full Text] [Related]
36. A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-EGFR.
Lau TS; Chan LK; Wong EC; Hui CW; Sneddon K; Cheung TH; Yim SF; Lee JH; Yeung CS; Chung TK; Kwong J
Oncogene; 2017 Jun; 36(25):3576-3587. PubMed ID: 28166193
[TBL] [Abstract][Full Text] [Related]
37. TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer.
Gao C; Yao H; Liu H; Feng Y; Yang Z
BMC Cancer; 2019 Mar; 19(1):237. PubMed ID: 30876464
[TBL] [Abstract][Full Text] [Related]
38. Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
Chuang TC; Hsu SC; Cheng YT; Shao WS; Wu K; Fang GS; Ou CC; Wang V
Cancer Lett; 2011 Dec; 311(1):11-9. PubMed ID: 21757288
[TBL] [Abstract][Full Text] [Related]
39. Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian Cancer.
Kitami K; Yoshihara M; Koya Y; Sugiyama M; Iyoshi S; Uno K; Mogi K; Tano S; Fujimoto H; Nawa A; Kikkawa F; Kajiyama H
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371469
[TBL] [Abstract][Full Text] [Related]
40. MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.
Zhao S; Zhang X; Shi Y; Cheng L; Song T; Wu B; Li J; Yang H
J Exp Clin Cancer Res; 2020 Dec; 39(1):286. PubMed ID: 33317572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]